The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML
Veronica Novotny‐Diermayr(Biotronik (Singapore)), J M Wood
Cited by 99
Related Papers
No related papers found
Powered by citation graph analysis